Why These 5 Stocks Are on the Move on Thursday

In this article we take a look at five stocks that are moving on Thursday. If you want to read our detailed analysis of these stocks, go to read Why These 10 Stocks Are on the Move on Thursday.

5. Perrigo Company plc (NYSE:PRGO) has surged 11% after the company settled a major tax bill in Ireland. According to the Irish Times, Perrigo Company plc (NYSE:PRGO) faced a tax bill of 1.6 billion euros ($1.85 billion). According to the news today, Perrigo Company plc (NYSE:PRGO) settled for considerably less. The number of elite funds in our database that were long Perrigo Company plc (NYSE:PRGO) fell to 28 in Q2, 2021 from 33 in Q1, 2021.

4. Herman Miller, Inc. (NASDAQ:MLHR) has fallen around 2.7% after the company reported adjusted quarterly earnings per share of $0.49, and revenue of $789.7 million for Q1. Herman Miller, Inc. (NASDAQ:MLHR) sees Q2 adjusted earnings per share of $0.55-$0.61. The number of elite funds long Herman Miller, Inc. (NASDAQ:MLHR) rose by 5 from the prior quarter to 23 at the end of the second quarter.

3. Virgin Galactic Holdings, Inc. (NYSE:SPCE) has soared almost 14% after the company announced it is “cleared to fly FAA-licenced spaceflights following the conclusion of an FAA inquiry that focused on air traffic control clearance and real-time mission notification related to the Unity 22 flight in July.” The news removes a regulatory headwind. Israel Englander‘s Millennium Management was long 700,321 shares of Virgin Galactic Holdings, Inc. (NYSE:SPCE) at the end of June.

2. Diageo plc (NYSE:DEO) is up around 1.7% after the company’s CEO, Ivan Menezes commented that Diageo plc (NYSE:DEO) has made a strong start to its fiscal 2022 year with organic net sales momentum across all of the company’s regions. If its sales grow faster, the company could find it easier to grow profits too. Of the around 873 elite funds in our database, 20 were long Diageo plc (NYSE:DEO) at the end of Q2.

1. AstraZeneca PLC (NASDAQ:AZN) is up around 1% after a clinical trail in the U.S. showed that the company’s COVID-19 vaccine had around 74% efficacy. The results could increase confidence in AstraZeneca PLC (NASDAQ:AZN)’s vaccine’s effectiveness abroad. Of the around 873 elite funds in our database, 37 were long AstraZeneca PLC (NASDAQ:AZN) at the end of the second quarter.

Disclosure: None.